- Dosage: Levofloxacin 300mg
- Volume: 100ml per Bottle
- Packaging: Sterile for injection, 60 bottles/carton
- Shelf Life: 36 months
Package:
Product Description
Levofloxacin Lactate Injection 100ml:300mg: What the Published Guidance Says
A broad portfolio spanning the WHO Access and Watch groups, supplied with the documentation that stewardship programmes and national tenders require.
Before Levofloxacin Lactate Injection 100ml:300mg is quoted, we confirm the monograph, the strength on the artwork and the release testing required by your market — the points summarised here.
- AWaRe is the framework buyers and stewards now work to WHO's AWaRe classification divides antibiotics into Access, Watch and Reserve. Access agents are described as those that should be widely available, affordable and quality-assured to improve access and promote appropriate use. Watch agents carry higher resistance potential and should be prioritised as targets of stewardship programmes and monitoring. WHO Antibiotics Portal — AWaRe
- WHO's own indication mapping is public — we align to it The WHO Antibiotics Portal lists amoxicillin as first choice for community-acquired pneumonia (mild to moderate), acute otitis media, acute sinusitis, acute pharyngitis and uncomplicated acute malnutrition in children; amoxicillin + clavulanic acid as first choice for severe community-acquired pneumonia in children, hospital-acquired pneumonia, cystitis and cellulitis; and ceftriaxone as first choice for severe acute pyelonephritis. WHO Antibiotics Portal — AWaRe
- Access group — the empirical workhorses The WHO AWaRe classification places amoxicillin, amoxicillin + clavulanic acid, ampicillin, clindamycin, gentamicin, metronidazole, chloramphenicol and doxycycline in the Access group. These are the medicines expected to be available in every functioning health system. WHO AWaRe (Access, Watch, Reserve) classification of antibiotics
We quote these sources rather than paraphrase them loosely, because the detail matters commercially for Levofloxacin Lactate Injection 100ml:300mg. Where your national list differs from the WHO listing, the national list governs what may be supplied and promoted locally.
Levofloxacin Lactate Injection 100ml:300mg: Specification, Pack & Documentation Summary
| Product Name | Levofloxacin Lactate Injection (Fluoroquinolone Antibacterial) |
| Specification | 100mL:300mg (3mg/mL, large-volume infusion solution) |
| Dosage Form | Sterile, Nonpyrogenic, Clear Solution for Intravenous Infusion |
| Active Ingredient | Levofloxacin (as Levofloxacin Lactate) |
| Pharmacological Class | Fluoroquinolone Antibacterial Agent / Synthetic Broad-Spectrum Antibiotic |
| Route of Administration | Intravenous infusion only (via a suitable IV administration set). NOT for intramuscular, subcutaneous, or bolus intravenous administration. |
| Storage | Store below 25°C, protected from light. Do not freeze. Keep in outer carton until use. |
| Therapeutic group | Antibacterials — Antibacterials |
| Manufacturer | Sinophare Bio-technology Co., Ltd. (GMP, China) |
| Documentation supplied | COA, HPLC/GC data, stability data, dossier package |
The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: Ciprofloxacin Lactate Injection 200mg/100mL, Amoxicillin Powder for Injection 1g, Netilmicin Injection 100mg/2ml, Metronidazole Injection 5mL:25mg, Gentamicin Injection 2mL:80mg, Clindamycin Injection 300mg/2mL, Ceftriaxone Powder for Injection 1g, Metronidazole Injection 500mg 100ml.
How Levofloxacin Lactate Injection 100ml:300mg Is Tested and Released
Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.
Every batch of Levofloxacin Lactate Injection 100ml:300mg is tested to the monograph stated on the purchase order. Where a monograph is silent on the presentation, we agree a written specification with you in advance and reference it on the certificate of analysis.
Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.
Release testing on this presentation is built around:
- Testing for uniformity of dosage units
- Testing for water content and pH where applicable
- Testing for sterility and bacterial endotoxins (parenterals and ophthalmics)
- Testing for microbial limits and preservative efficacy (multi-dose presentations)
- Testing for heavy metals and elemental impurities
- Testing for packaging integrity and seal testing
COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.
How Levofloxacin Lactate Injection 100ml:300mg Is Packed, Labelled and Shipped
- Pack size: 100mL clear glass infusion bottle or PVC/non-PVC infusion bag. Non-standard pack sizes can be quoted against your artwork.
- Storage: Store below 25°C, protected from light. Do not freeze. Keep in outer carton until use..
- Shelf life: 36 months (unopened). Stability data for the marketed pack is included in the dossier.
- Labelling: artwork can be produced in English, Arabic, French, Russian and Spanish, with your own brand and language mix, subject to the labelling rules of the destination market.
- Export: GMP certificate, COA, certificate of origin, packing list and, where required, the free-sale or marketing authorisation certificate from the country of manufacture.
Regulatory Support for Levofloxacin Lactate Injection 100ml:300mg
Documents for Levofloxacin Lactate Injection 100ml:300mg are issued by Sinophare Bio-technology Co., Ltd. — DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. Keeping one legal manufacturer across the COA, the GMP certificate and the registration file avoids assessment queries later.
- Batch manufacturing and packaging records released for inspection on request during supplier audits.
- Re-test or renewal support when the marketing authorisation comes up for variation or renewal.
- CTD dossier modules 1–5 in editable and PDF form, with the finished-product and API sections cross-referenced.
- Site Master File and GMP certificate for the manufacturing workshops.
- Method validation, stability protocol and the shelf-life justification for the marketed pack.
The context for Levofloxacin Lactate Injection 100ml:300mg is its place among antibacterials classified in the WHO AWaRe framework. Listing status informs how programmes specify a product; it is not a substitute for the import licence or marketing authorisation of the destination country.
Questions We Are Asked About Levofloxacin Lactate Injection 100ml:300mg
What pack size is available for Levofloxacin Lactate Injection 100ml:300mg?
This presentation is normally supplied as 100mL clear glass infusion bottle or PVC/non-PVC infusion bag. Where your market requires a different count, bottle or carton, we quote to your artwork and extend the stability file to the new pack.
What documentation comes with a shipment of Levofloxacin Lactate Injection 100ml:300mg?
Shipments are accompanied by a certificate of analysis covering identification, assay and related substances, together with the marketed-pack stability data and the manufacturing site GMP certificate. Shelf life: 36 months.
Does the batch documentation for Levofloxacin Lactate Injection 100ml:300mg support a registration filing?
Shipments are accompanied by a certificate of analysis covering identification, assay and related substances, together with the marketed-pack stability data and the manufacturing site GMP certificate. Shelf life: 36 months. The full CTD dossier and the authority assessment file are supplied as part of a registration order; routine shipments carry the COA and stability data only.
Do you supply amoxicillin + clavulanic acid in paediatric ratios?
We supply both the 400/57 mg chewable tablet and the 200/28.5 mg per 5 mL oral suspension presentations used in paediatric formularies.
How do you handle stewardship restrictions?
Watch-group orders are supplied against documented purchase requirements. We can provide AWaRe classification reference material to support your tender or formulary documentation.
Companion Products — Antibacterials
- Ciprofloxacin Lactate Injection 200mg/100mL — 200mg/100mL
- Amoxicillin Powder for Injection 1g — 1g
- Netilmicin Injection 100mg/2ml — 100mg/2mL
- Metronidazole Injection 5mL:25mg — 25mg/5mL
- Gentamicin Injection 2mL:80mg — 80mg/2mL
- Clindamycin Injection 300mg/2mL — 300mg/2mL
Browse the full Antibacterials range; all Injectables; the complete product catalogue.
Request a Quotation for Levofloxacin Lactate Injection 100ml:300mg
For tenders and programme supply, send the line item, pack size, quantity and destination for Levofloxacin Lactate Injection 100ml:300mg 100mL. We return a quotation with lead time, documentation list and sample availability in one response.
Sources & Regulatory Notes
Reference information only. The published guidance summarised on this page is quoted for professional and regulatory-context purposes and does not constitute medical advice, a prescribing recommendation or a promotion of any product for a particular indication. Prescribing decisions must follow the approved product information and national treatment guidelines in the market of use.
